Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment.
Pérez-Olmeda
Mayte
M
Infectious Disease Service, Hepatology Unit, Institute de Salud Carlos III, Madrid, Spain.
Ríos
Pilar
P
Núñez
Marina
M
García-Samaniego
Javier
J
Romero
Miriam
M
Soriano
Vincent
V
D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000150:complications*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D008297:Male; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D014766:Viremia / Q000150:complications / Q000188:drug therapy / Q000821:virology
D000998:Antiviral Agents; D007370:Interferon Type I; D012367:RNA, Viral; D011994:Recombinant Proteins; D012254:Ribavirin